Tennessee-based insurtech provider Clover Health announced a partnership with mental and behavioral health platform Quartet Health, which will bring value-based behavioral healthcare to Clover members with severe mental illness through Clover Home Care.
Clover Home Care delivers care access, medication support, mental and physical care coordination and community resources to seniors. Clover supports Medicare Advantage plans.
Quartet’s Whole Health will add in-person or virtual therapy or psychiatry plus self-guided programs to Clover’s offerings.
The service matches patients with mental health professionals based on preferences, needs and insurance. Providers can also refer patients to the service.
Quartet Clinicians will use the Clover Assistant platform, an AI tool that aggregates data to help health providers make decisions regarding chronic conditions. Their platform now includes offerings to help individuals with serious mental illness.
“Patients are often forced to navigate an incredibly fragmented healthcare system, a system that fails to meet their needs, contributes to unnecessary hospitalizations and, ultimately, worse outcomes. That’s why it was so critical for us, in developing our Whole Health program, to take an approach that treats the whole person in a way that improves quality and patient outcomes, while also lowering the cost of care,” Christina Mainelli, CEO of Quartet Health, told MobiHealthNews in an email.
THE LARGER TREND
In December of 2021, Quartet Health announced it acquired fellow virtual mental health company InnovaTel Telepsychiatry. The acquisition enabled Quartet to grow capacity and delivery capabilities.
The announcement came days after a $60 million funding round and partnership announcement with Independence Health Group. The deal allowed Quartet to grow its patient identification tools and expand its ability to support additional conditions.
Last year, Clover Health settled multiple lawsuits that alleged the insurtech company was under active investigation when it went public in 2021.
The same year, Clover avoided a stock delisting after regaining compliance with the minimum bid price requirement of closing at $1 or more per share for at least 10 consecutive days. At the time this article was published, Clover was trading on the NASDAQ at $0.88 per share.
In December, Clover Health elected to exit the Center for Medicaid and Medicaid Services ACO REACH program, which supports care delivery and coordination for people in underserved communities.
However, the Tennessee-based company posted an upward trend in 2023’s Q4 earnings report and has been cutting down on losses since 2022.
Credit: Source link
